METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in slowing advanced neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) compared to a placebo. About 298 adults whose cancer worsened after prior treatment will receive either cabozantinib or a placebo pill. The main goal …
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Experimental combo targets lung cancer brain metastases in early trial
Disease control OngoingThis early-phase trial is testing the safety and best dose of a drug called berzosertib when given together with whole brain radiation therapy. The study includes 15 people with lung cancer that has spread to the brain. The goal is to find out if this combination is safe enough t…
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC